Recursion Pharmaceuticals (RXRX) Return on Equity [ROE] (2021 - 2026)
Recursion Pharmaceuticals (RXRX) posted Return on Equity [ROE] of -53.50% for Q2 2026, up 16.56 percentage points from -70.06% a year earlier but down 1.56 percentage points from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Recursion Pharmaceuticals' Return on Equity [ROE] came in at -59.54%, up 2.35 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a four-year change of +51.24 percentage points (FY2021 to FY2025).
- In prior years, Recursion Pharmaceuticals' Return on Equity [ROE] was -61.89% in FY2024 (+7.23 pp), -69.12% in FY2023 (-22.56 pp), -46.56% in FY2022 (+64.23 pp) and -110.79% in FY2021.
- Quarterly Return on Equity [ROE] has run from a low of -81.91% in Q1 2024 to a high of -23.10% in Q3 2021 over five years.
- On a year-over-year basis, Return on Equity [ROE] has increased in each of the last three quarters, with an average year-over-year change of +7.33 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2025, with a gain of 23.52 percentage points; the weakest was Q3 2022, with a drop of 37.39 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -51.94% (Q1 2026), -59.21% (Q4 2025) and -72.79% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Recursion Pharmaceuticals | 2.20 Bn | -402.71 Mn | -3.82 Mn | -53.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53.50% |
| Mar 31, 2026 | -51.94% |
| Dec 31, 2025 | -59.21% |
| Sep 30, 2025 | -72.79% |
| Jun 30, 2025 | -70.06% |
| Mar 31, 2025 | -58.39% |
| Dec 31, 2024 | -59.47% |
| Sep 30, 2024 | -68.12% |
| Jun 30, 2024 | -76.08% |
| Mar 31, 2024 | -81.91% |
| Dec 31, 2023 | -72.79% |
| Sep 30, 2023 | -65.29% |
| Jun 30, 2023 | -59.08% |
| Mar 31, 2023 | -55.69% |
| Dec 31, 2022 | -56.24% |
| Sep 30, 2022 | -60.49% |
| Jun 30, 2022 | -50.16% |
| Mar 31, 2022 | -40.19% |
| Dec 31, 2021 | -32.01% |
| Sep 30, 2021 | -23.10% |
API Access
Recursion Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();